Ultrasound is an acceptable alternative to biopsy for the management of tumors hidden to x-ray mammography but diagnosed as probably benign under the ultrasound Breast Imaging Reporting and Data System, according to a study in the July issue of Radiology.
Ultrasound is an acceptable alternative to biopsy for the management of tumors hidden to x-ray mammography but diagnosed as probably benign under the ultrasound Breast Imaging Reporting and Data System, according to a study in the July issue of Radiology.
Investigators at the Ambulatory Care Center in Steyr, Austria, retrospectively evaluated 445 nonpalpable solid masses from 409 women who underwent ultrasound between January 2001 and December 2003. These masses were partially or completely obscured by dense breast tissue on mammography but were classified as probably benign by ultrasound. Of the 445 masses, 442 remained stable during a mean follow-up of more than three years. The false-negative rate and negative predictive value of the test were 0.2% and 99.8%, respectively.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.